Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entelon vs Doxium in Nonproliferative Diabetic Retinopathy
NCT03962296Phase 4Completed
- Sponsor
- Hanyang University
- Start
- Nov 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of grape seed extract in diabetic retinopathy (DR), sponsored by Hanyang University. Started Nov 2012; status: completed.
02
Drugs
grape seed extract
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT03962296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03962296.